Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Sleep Aids market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
The Sleep Aids market in Georgia is experiencing significant growth and development.
Customer preferences: Customers in Georgia are increasingly seeking ways to improve their sleep quality and address sleep disorders. This growing awareness of the importance of good sleep health is driving the demand for sleep aids in the market. Additionally, the rise in stress levels and busy lifestyles has led to an increase in sleep-related issues, further fueling the demand for sleep aids.
Trends in the market: One of the key trends in the Sleep Aids market in Georgia is the growing popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of synthetic sleep aids and are opting for natural alternatives. This trend is driven by the increasing availability of natural sleep aids in the market and the perception that they are safer and have fewer side effects.Another trend in the market is the rising demand for sleep aids among the aging population. As the population in Georgia continues to age, there is a higher prevalence of sleep disorders among older adults. This has created a significant market opportunity for sleep aids targeted specifically towards this demographic.
Local special circumstances: Georgia has a relatively high prevalence of sleep disorders compared to other countries in the region. This can be attributed to various factors such as stress, lifestyle changes, and the impact of modern technology on sleep patterns. The local healthcare system is also well-equipped to diagnose and treat sleep disorders, which further contributes to the demand for sleep aids in the market.
Underlying macroeconomic factors: The growing economy in Georgia has resulted in increased disposable income among consumers. This has allowed individuals to prioritize their health and well-being, including investing in sleep aids. Furthermore, the expanding middle class in the country has also contributed to the growth of the Sleep Aids market.In conclusion, the Sleep Aids market in Georgia is experiencing growth and development due to customer preferences for natural sleep aids, the rising demand among the aging population, the high prevalence of sleep disorders in the country, and the favorable macroeconomic factors. As the market continues to evolve, it is expected that new products and innovations will emerge to cater to the changing needs and preferences of customers in Georgia.
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights